Business
Australian government backs psychedelic drug clinical trials to treat mental illness – The Guardian
$15m grant comes despite TGA’s failure to reschedule MDMA and psilocybin from a prohibited substance to a controlled medicine
The use of magic mushrooms, ecstasy and other psychedelic drugs to treat mental illnesses, including depression and post-traumatic stress disorder, may be a step closer in Australia, with clinical trials given a $15m grant.
Despite international evidence suggesting the medicinal effectiveness of psychedelic drugs to treat mental health conditions, the Australian Therapeutic Drug Association last month made an interim decision against rescheduling MDMA and psilocybin from a prohibited substance (schedule…
-
General22 hours agoChina was the big disruptor in our region. Now the US is determined to take that title
-
General22 hours agoSpaceX to invest $3 billion in Musk’s xAI startup
-
General18 hours agoWimbledon men’s final, Jannik Sinner vs Carlos Alcaraz live updates — blog, scores and stats
-
General10 hours agoJannik Sinner reveals secret Wimbledon bet that could keep Darren Cahill in his team